Supriya Lifescience Limited Supriya Lifescience Reports 11.2% Revenue Growth in Q3 FY26 Driven by Anesthetic Segment and Export Demand 7 hours ago Supriya Lifescience Limited (NSE: SUPRIYA) the active pharmaceutical ingredient manufacturer recorded increased top-line performance supported by higher capacity utilization and…